Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins: Gliosarcoma trials
The registry lists 34 Gliosarcoma studies with Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins as lead sponsor. 0 are open to participants now and 8 have results posted.
Phase 1 16Phase 2 18No phase 7(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGGTerminatedNCT03973918Phase 2Results posted
- Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma MultiformeCompletedNCT00895180Phase 2Results posted
- Testosterone Gel in Preventing Weakness Caused by Steroid Therapy in Men With GliomaTerminatedNCT00631137Not applicableResults posted
- Hydroxychloroquine, Radiation, and Temozolomide Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00486603Phase 1/2Results posted
- Tetra-O-Methyl Nordihydroguaiaretic Acid in Treating Patients With Recurrent High-Grade GliomaCompletedNCT00404248Phase 1/2Results posted
- Radiation Therapy and Temozolomide Followed by Temozolomide and Poly ICLC in Treating Patients With Newly Diagnosed GBMCompletedNCT00262730Phase 2Results posted
- Celecoxib in Patients With Newly Diagnosed GBM Who Are Receiving Anticonvulsant Drugs and Undergoing RTTerminatedNCT00068770Phase 2Results posted
- Biological Therapy and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeTerminatedNCT00052715Phase 2Results posted
- Pilot Study Using Amide Proton Transfer Magnetic Resonance Imaging Distinguishing GliomaTerminatedNCT03843814Not applicable
- Anti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16/18)CompletedNCT02658981Phase 1
- Study of Blood Samples and Risk of Infection in Patients With Newly Diagnosed Malignant Supratentorial AstrocytomaCompletedNCT00999622
- Tumor DNA and MRI/CT Scan Findings in Patients With Grade III or Grade IV Malignant GliomaCompletedNCT00897611Not applicable
- ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00770471Phase 1
- Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation TherapyTerminatedNCT00471653
- MRI in Evaluating the Effect of Efaproxiral on the Brain in Patients With Recurrent or Progressive Glioma Enrolled on Clinical Trial NABTT-9806WithdrawnNCT00433472Not applicable
- Tumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant GliomaCompletedNCT00401024Phase 1
- Gossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00390403Phase 1
- Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed GliomasCompletedNCT00253669
- Temozolomide During and After Radiation Therapy in Treating Patients Who Have Undergone Previous Surgery and Placement of Gliadel Wafers for Newly Diagnosed Glioblastoma MultiformeTerminatedNCT00238277Phase 2
- Gefitinib Plus Temozolomide in Treating Patients With Malignant Primary GliomaCompletedNCT00027625Phase 1
- Gefitinib in Treating Patients With Recurrent or Progressive CNS TumorsCompletedNCT00025675Phase 2
- CCI-779 in Treating Patients With Malignant GliomaCompletedNCT00022724Phase 1/2
- Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or MeningiomaCompletedNCT00010049Phase 1/2
- Gadolinium Texaphyrin Plus Radiation Therapy in Treating Patients With Supratentorial Glioblastoma MultiformeCompletedNCT00006452Phase 1
- Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain TumorCompletedNCT00006358Phase 2
- Pyrazoloacridine Followed by Radiation Therapy in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma MultiformeCompletedNCT00006355Phase 1/2
- Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant GliomaCompletedNCT00006025Phase 1
- Tipifarnib in Treating Patients With Recurrent or Progressive Malignant GliomaCompletedNCT00005859Phase 1/2
- SU5416 in Treating Patients With Recurrent Astrocytoma or Mixed Glioma That Has Not Responded to Radiation TherapyCompletedNCT00004868Phase 1/2
- Suramin Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00004073Phase 2
- Gene Therapy in Treating Patients With Recurrent Malignant GliomasCompletedNCT00004041Phase 1
- Penicillamine, Low Copper Diet, and Radiation Therapy in Treating Patients With GlioblastomaCompletedNCT00003751Phase 2
- Temozolomide and Carmustine in Treating Patients With Anaplastic GliomaCompletedNCT00003176Phase 2
- O(6)-Benzylguanine in Treating Patients With Malignant GliomaCompletedNCT00002971Phase 1